Leqvio 284 MG/1.5 ML syringe 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT4KJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,508
Award facts
- Contract value 100% obligated
- $24,507.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,507.70 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 mL syringes on December 3, 2025, with an ultimate completion date of December 24, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle that runs through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical federal medical procurement vendor supplying a broad range of pharmaceutical products and medical supplies to military and veteran healthcare systems. LEQVIO, a PCSK9 inhibitor used for cardiovascular disease management, represents one of the specialized pharmaceutical products the company delivers through its federal contracts. This delivery order exemplifies AmerisourceBergen's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through flexible contract vehicles designed to meet critical medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FT4KJ?
SPE2DR26FT4KJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FT4KJ worth?
The government has obligated $24,508 on SPE2DR26FT4KJ.
Is contract SPE2DR26FT4KJ an order under another contract?
Yes. SPE2DR26FT4KJ is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4KJ competed?
The extent of competition for SPE2DR26FT4KJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award